A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (ar2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma

Hematological oncology(2023)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要